Star Health’s Q1 FY27 normalised profit rises 44% as retail health premiums grow
Star Health reported normalised PAT of ₹386 crore for Q1 FY27, up 44% year on year, while fresh retail health gross written premium rose 37% to ₹730 crore. Underwriting profit increased to ₹111 crore from ₹16 crore, with digital D2C contributing 16% of fresh retail sales.
The development
Star Health reported stronger Q1 FY27 profitability and premium growth, supported by underwriting discipline, digital D2C sales and a large agent-hospital network. Fresh retail health premiums rose 37%, while its digital channel contributed 16% of new retail sales.
The numbers
- Normalised PAT: ₹386 crore, up 44% YoY
- Ind AS PAT: ₹550 crore, up 25% YoY
- Gross written premium: ₹4,287 crore, up 19% YoY
- Fresh retail health GWP: ₹730 crore, up 37% YoY
- Underwriting profit: ₹111 crore versus ₹16 crore
- Digital D2C channel: 16% of fresh retail sales, up 142% YoY
- 97% of fresh policies sourced digitally
- 900+ branches; 8.5 lakh+ agents; 16,000+ network hospitals
Why it matters to operators and investors
Star Health’s growing D2C contribution and accelerating retail-premium base make it a stronger potential partner for digital-health, distribution and embedded-insurance platforms.
What to watch next
- Retail health GWP growth and fresh-policy volumes in Q2 and Q3.
- Combined ratio, loss ratio and underwriting profit trajectory versus the Q1 ₹111 crore level.
- D2C share of fresh retail sales, customer acquisition cost and digital-policy renewal rates.
- Medical inflation, claims frequency/severity and reserve-development commentary.
- Competitive pricing and growth actions by large private health insurers.
- Regulatory changes affecting health-insurance pricing, commissions, product design or claims servicing.
- Increase digital D2C spend and conversion-led marketing, using the 16% fresh-sales contribution as proof of channel scalability.
- Prioritize renewal retention, cross-sell and risk-based pricing to raise customer lifetime value rather than chase only new-policy volume.
- Expand hospital-network negotiations, claims analytics and fraud controls to protect loss ratios amid medical-cost inflation.
- Use stronger profitability to support selective agent productivity investments and product launches in underpenetrated retail segments.
The counter-case
The 44% rise in normalised profit and 37% growth in fresh retail premium may overstate underlying momentum if Q1 claims were unusually benign, the prior-year underwriting base was weak, or “normalised” earnings exclude meaningful investment, reserve or one-off costs. Fresh GWP growth does not establish renewal retention, policy persistency, claims quality or lifetime profitability. The jump in underwriting profit from ₹16 crore to ₹111 crore needs validation against loss ratios, combined ratio, reserve releases and reinsurance costs. A 16% D2C contribution can improve distribution economics, but could also require sustained marketing spend and face digital customer-acquisition churn.